{
    "organizations": [],
    "uuid": "64e5b44a1386cb440dcaf13d956d1af47ed6c23f",
    "author": "",
    "url": "https://www.reuters.com/article/brief-pixium-vision-gets-fda-approval-fo/brief-pixium-vision-gets-fda-approval-for-human-clinical-study-of-prima-sub-retinal-implant-idUSASM000HPT",
    "ord_in_thread": 0,
    "title": "BRIEF-Pixium Vision Gets FDA Approval For Human Clinical Study Of Prima Sub-Retinal Implant",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 4 (Reuters) - PIXIUM VISION SA:\n* PIXIUM VISION RECEIVES FDA APPROVAL TO BEGIN HUMAN CLINICAL STUDY OF ITS PRIMA SUB-RETINAL IMPLANT IN THE US\n* RECEIVES FDA APPROVAL TO BEGIN HUMAN CLINICAL STUDY OF ITS PRIMA SUB-RETINAL IMPLANT IN US\n* FEASIBILITY CLINICAL STUDY IS DESIGNED TO EVALUATE PRIMA IN PATIENTS WITH ATROPHIC DRY AGE-RELATED MACULAR DEGENERATION\n* EXPECTS TO START US STUDY IN FIRST HALF OF 2018. Source text for Eikon: Further company coverage: (Gdynia Newsroom:)\nOur Standards: The Thomson Reuters Trust Principles.",
    "published": "2018-01-04T08:06:00.000+02:00",
    "crawled": "2018-01-04T08:11:37.012+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "pixium",
        "vision",
        "sa",
        "pixium",
        "vision",
        "receives",
        "fda",
        "approval",
        "begin",
        "human",
        "clinical",
        "study",
        "prima",
        "implant",
        "u",
        "receives",
        "fda",
        "approval",
        "begin",
        "human",
        "clinical",
        "study",
        "prima",
        "implant",
        "u",
        "feasibility",
        "clinical",
        "study",
        "designed",
        "evaluate",
        "prima",
        "patient",
        "atrophic",
        "dry",
        "macular",
        "degeneration",
        "expects",
        "start",
        "u",
        "study",
        "first",
        "half",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}